All industry news
RegulationJune 12, 2026

Wave Neuroscience wins FDA clearance for precision PTSD therapy

Wave Neuroscience received FDA clearance for its MeRT platform, which uses transcranial magnetic stimulation (TMS) tailored to individual patient brain data for PTSD treatment. The system records patient-specific neural activity to customize stimulation parameters, enabling personalized therapy delivery.

The source

This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.

Read the full story at Medical Device Network
MedIndexer aggregates and summarises publicly available headlines. Full article text remains the property of the originating publication.